ReviewActa gastroenterologica Latinoamericana
[Lactose Malabsorption and Intolerance].
Review in Acta gastroenterologica Latinoamericana. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Frequency and Diagnostic Utility of the -13910C>TIn vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lactose malabsorption and lactose intolerance are common yet clinically distinct conditions. Lactose malabsorption refers to the passage of undigested lactose into the colon due to lactase deficiency, whereas lactose intolerance involves the onset of gastrointestinal symptoms following lactose ingestion in the presence of malabsorption. Alactasia is a rare congenital disorder characterized by complete absence of lactase activity. Primary hypolactasia is a physiological and genetically determined decline in lactase activity occurring in adulthood. Globally, the prevalence of lactose malabsorption affects up to two-thirds of the population, with particularly high rates in Latin America and Mexico. Diagnosis can be established through non-invasive methods such as the hydrogen breath test, genetic testing, the gaxilose test, and lactose tolerance testing, or through invasive procedures like enzymatic activity measurement in duodenal biopsies. Management should aim to control symptoms without compromising nutritional status and may include low-lactose diets, oral lactase enzyme supplementation, and the use of probiotics or prebiotics. Avoiding unnecessary dietary restrictions is essential to prevent nutritional deficiencies or the development of avoidant/restrictive food intake disorder. An individualized diagnostic and therapeutic approach improves both clinical outcomes and quality of life in affected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.